The cells, which the Madison-based company will create using pluripotent stem cell technology to reprogram blood and skin samples, will be part of an effort to fight macular degeneration, a condition that leads to loss of vision. The cells can be implanted into a patient's eyes to treat the disorder.
http://ift.tt/130Rjve
http://ift.tt/130Rjve
No comments:
Post a Comment